Liu Song Yin
Chief Executive Officer at Sunho Biologics, Inc.
Profile
Liu Song Yin is currently the CEO, Executive Director & Chief Scientific Officer at Sunho Biologics, Inc. He is also a Director at Sunho Bio Investments Ltd., Sunho Hk Ltd., Sunho Pharmaceutical Technology Zhejiang Anji Co. Ltd., and Nanjing Sunho Medical Technology Co., Ltd.
In 2020, he became the Chief Executive & Scientific Officer at SunHo (China) Biopharmaceutical Co. Ltd.
Prior to his current positions, he worked as an Executive Director at Genscript Biotech Corp.
from 2015 to 2020.
Dr. Yin completed his undergraduate degree at the University of Science & Technology of China in 2008 and obtained his doctorate from UMass Chan Medical School in 2014.
Liu Song Yin active positions
| Companies | Position | Start |
|---|---|---|
Sunho Biologics, Inc.
 Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | Chief Executive Officer | 2023-07-21 |
| SunHo (China) Biopharmaceutical Co. Ltd. | Chief Executive Officer | 2020-10-31 |
Former positions of Liu Song Yin
| Companies | Position | End |
|---|---|---|
| GENSCRIPT BIOTECH CORPORATION | Director/Board Member | 2020-09-30 |
Training of Liu Song Yin
| University of Science & Technology of China | Undergraduate Degree |
| UMass Chan Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
 | Health Technology |
| GENSCRIPT BIOTECH CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
| SunHo (China) Biopharmaceutical Co. Ltd. |
- Stock Market
- Insiders
- Liu Song Yin
